These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 34791066)

  • 21. Mycophenolate mofetil in juvenile dermatomyositis: a case series.
    Dagher R; Desjonquères M; Duquesne A; Quartier P; Bader-Meunier B; Fischbach M; Guiguonis V; Picherot G; Cimaz R
    Rheumatol Int; 2012 Mar; 32(3):711-6. PubMed ID: 21152922
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Muscle shear wave elastography, conventional B mode and power doppler ultrasonography in healthy adults and patients with autoimmune inflammatory myopathies: a pilot cross-sectional study.
    Paramalingam S; Needham M; Raymond W; Mastaglia F; Lightowler D; Morin N; Counsel P; Keen HI
    BMC Musculoskelet Disord; 2021 Jun; 22(1):537. PubMed ID: 34118902
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone mineral apparent density in juvenile dermatomyositis: the role of lean body mass and glucocorticoid use.
    Santiago RA; Silva CA; Caparbo VF; Sallum AM; Pereira RM
    Scand J Rheumatol; 2008; 37(1):40-7. PubMed ID: 18189194
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Importance of aggressive treatment in juvenile dermatomyositis].
    Vojinović J; Riley P; Maillard S; Pilkington C
    Srp Arh Celok Lek; 2005 Dec; 133 Suppl 2():118-23. PubMed ID: 16535995
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angioedema-like presentation as the presenting finding of juvenile myositis and juvenile dermatomyositis in 2 patients.
    Karaca Ö; Güngör M; Sakarya Güneş A; Eser Şimşek I; Anık Y; Kara B
    Int J Rheum Dis; 2022 May; 25(5):617-625. PubMed ID: 35238477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Whole-body MR imaging in evaluation of children with juvenile dermatomyositis.
    Sreelal Tv ; Bhatia A; Suri D; Singh S; Saxena AK; Tao TY; Sodhi KS
    Eur J Radiol; 2022 Oct; 155():110475. PubMed ID: 35998441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Whole-body magnetic resonance imaging in the assessment of muscular involvement in juvenile dermatomyositis/polymyositis patients.
    Castro TC; Lederman H; Terreri MT; Caldana WI; Zanoteli E; Hilário MO
    Scand J Rheumatol; 2014; 43(4):329-33. PubMed ID: 25087579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MHC class I and II expression in juvenile dermatomyositis skeletal muscle.
    Sallum AM; Kiss MH; Silva CA; Wakamatsu A; Sachetti S; Lotufo S; Matsumura N; Marie SK
    Clin Exp Rheumatol; 2009; 27(3):519-26. PubMed ID: 19604449
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of interferon-regulated genes in juvenile dermatomyositis versus Mendelian autoinflammatory interferonopathies.
    Kim H; Gunter-Rahman F; McGrath JA; Lee E; de Jesus AA; Targoff IN; Huang Y; O'Hanlon TP; Tsai WL; Gadina M; Miller FW; Goldbach-Mansky R; Rider LG
    Arthritis Res Ther; 2020 Apr; 22(1):69. PubMed ID: 32252809
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel associations between cytokines and pulmonary involvement in juvenile dermatomyositis - a cross-sectional study of long-term disease.
    Marstein H; Schwartz T; Aaløkken TM; Lund MB; Flatø B; Sjaastad I; Sanner H
    Rheumatology (Oxford); 2020 Aug; 59(8):1862-1870. PubMed ID: 31740970
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Feasibility of the wingate anaerobic exercise test as a clinical measure in patients with juvenile dermatomyositis.
    Dover S; Stephens S; Clairman H; Abesamis A; Jazi OA; Babij S; Marcuz JA; Naraidoo N; Pan J; Pullenayegum E; Rumsey D; Whitney K; Feldman BM
    Pediatr Rheumatol Online J; 2022 Mar; 20(1):21. PubMed ID: 35346243
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An international consensus survey of the diagnostic criteria for juvenile dermatomyositis (JDM).
    Brown VE; Pilkington CA; Feldman BM; Davidson JE;
    Rheumatology (Oxford); 2006 Aug; 45(8):990-3. PubMed ID: 16467366
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Juvenile dermatomyositis.
    Quartier P; Gherardi RK
    Handb Clin Neurol; 2013; 113():1457-63. PubMed ID: 23622367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical signs and symptoms in a joint model of four disease activity parameters in juvenile dermatomyositis: a prospective, longitudinal, multicenter cohort study.
    van Dijkhuizen EHP; De Iorio M; Wedderburn LR; Deakin CT;
    Arthritis Res Ther; 2018 Aug; 20(1):180. PubMed ID: 30111380
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Muscle abnormalities in juvenile dermatomyositis patients: P-31 magnetic resonance spectroscopy studies.
    Park JH; Niermann KJ; Ryder NM; Nelson AE; Das A; Lawton AR; Hernanz-Schulman M; Olsen NJ
    Arthritis Rheum; 2000 Oct; 43(10):2359-67. PubMed ID: 11037897
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Features distinguishing clinically amyopathic juvenile dermatomyositis from juvenile dermatomyositis.
    Mamyrova G; Kishi T; Targoff IN; Ehrlich A; Curiel RV; Rider LG;
    Rheumatology (Oxford); 2018 Nov; 57(11):1956-1963. PubMed ID: 30016492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endothelial Activation Markers as Disease Activity and Damage Measures in Juvenile Dermatomyositis.
    Kishi T; Chipman J; Evereklian M; Nghiem K; Stetler-Stevenson M; Rick ME; Centola M; Miller FW; Rider LG
    J Rheumatol; 2020 Jul; 47(7):1011-1018. PubMed ID: 31371656
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Skin involvement in juvenile dermatomyositis is associated with loss of end row nailfold capillary loops.
    Smith RL; Sundberg J; Shamiyah E; Dyer A; Pachman LM
    J Rheumatol; 2004 Aug; 31(8):1644-9. PubMed ID: 15290747
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Magnesium abnormalities of skeletal muscle in dermatomyositis and juvenile dermatomyositis.
    Niermann KJ; Olsen NJ; Park JH
    Arthritis Rheum; 2002 Feb; 46(2):475-88. PubMed ID: 11840451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and Testing of a Hybrid Measure of Muscle Strength in Juvenile Dermatomyositis for Use in Routine Care.
    Varnier GC; Rosina S; Ferrari C; Pistorio A; Consolaro A; Bovis F; Dalprà S; Pilkington C; Maillard S; Civino A; Tsitsami E; de Inocencio J; Jelusic M; Vojinovic J; Espada G; Makay B; Katsicas MM; Pratsidou-Gertsi P; Lazarevic D; Rao AP; Marafon DP; Ruperto N; Martini A; Ravelli A
    Arthritis Care Res (Hoboken); 2018 Sep; 70(9):1312-1319. PubMed ID: 29245175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.